Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Antibiotics Chapter 09
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AntibioticsAntibiotics
Chapter 09
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AntibioticsAntibiotics
• Antibiotics are defined as:
– Chemicals that inhibit specific bacteria
– Made in three ways
• By living microorganisms
• By synthetic manufacture
• Through genetic engineering
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Types of AntibioticsTypes of Antibiotics
• Bacteriostatic
– Those substances that prevent the growth of bacteria
• Bactericidal
– Those that kill bacteria directly
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Signs of InfectionSigns of Infection
• Fever
• Lethargy
• Slow-wave sleep induction
• Classic signs of inflammation (redness, swelling, heat, and pain)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Goal of Antibiotic TherapyGoal of Antibiotic Therapy
• Decrease the population of the invading bacteria to a point where the human immune system can effectively deal with the invader
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Selecting TreatmentSelecting Treatment
• Identification of the causative organism
• Based on the culture report, an antibiotic is chosen that has been known to be effective at treating the invading organism
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Bacteria ClassificationBacteria Classification
• Gram-positive
– The cell wall retains a stain or resists decolorization with alcohol
• Gram-negative
– The cell wall loses a stain or is decolorized by alcohol
• Aerobic
– Depend on oxygen for survival
• Anaerobic
– Do not use oxygen
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Bacteria and Resistance to AntibioticsBacteria and Resistance to Antibiotics
• Adapt to their environment
• The longer an antibiotic has been in use, the greater the chance that the bacteria will develop into a resistant strain
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AminoglycosidesAminoglycosides
• A group of powerful antibiotics used to treat serious infections caused by gram-negative aerobic bacilli
• Common medications:
– Amikacin (Amikin)
– Gentamicin (Garamycin)
– Kanamycin (Kantrex)
– Neomycin (Mycifradin)
– Streptomycin
– Tobramycin (Nebcin, Tobrex)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Aminoglycosides (cont.)Aminoglycosides (cont.)
• Bactericidal
• Indications: Treatment of serious infections caused by susceptible bacteria
• Actions: Inhibits protein synthesis in susceptible strains of gram-negative bacteria causing cell death
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Aminoglycosides (cont.)Aminoglycosides (cont.)
• Pharmacokinetics
– Poorly absorbed from the GI tract, but rapidly absorbed after IM injection, reaching peak levels within 1 hour
– Widely distributed throughout the body, crossing the placenta and entering breast milk
– Excreted unchanged in the urine and have an average half-life of 2 to 3 hours
– Depend on the kidney for excretion and are toxic to the kidney
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Aminoglycosides (cont.)Aminoglycosides (cont.)
• Contraindications
– Known allergies, renal or hepatic disease, hearing loss
• Adverse Effects
– Ototoxicity and nephrotoxicity are the most significant
• Drug-to-Drug Interactions
– Diuretics, neuromuscular blockers
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
Tell whether the following statement is true or false.
Because of the adverse effects of the aminoclycosides, it is important to teach the patient to restrict fluids and eat 6
small meals daily.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
False
Rationale: Provide the following patient teaching: Try to drink a lot of fluids and to maintain nutrition (very
important) even though nausea, vomiting, and diarrhea may occur.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Aminoglycosides
Nursing Considerations for Patients Receiving Aminoglycosides
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: GentamicinPrototype Summary: Gentamicin
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
CarbapenemsCarbapenems
• Therapeutic Actions and Indications
• Pharmacokinetics
• Contraindications and Cautions
• Adverse Effects
• Clinically Important Drug–Drug Interactions
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Carbapenems
Nursing Considerations for Patients Receiving Carbapenems
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: ErtapenemPrototype Summary: Ertapenem
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
CephalosporinsCephalosporins
• Similar to penicillin in structure and activity
• Action
– Interfere with the cell wall–building ability of bacteria when they divide
• Indications
– Treatment of infections caused by susceptible bacteria
• Pharmacokinetics
– Well absorbed from the GI tract
– Metabolized in the liver, excreted in the urine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Cephalosporins (cont.)Cephalosporins (cont.)
• Contraindications
– Allergies to cephalosporins or penicillin
• Adverse Effects
– GI track
• Drug-to-Drug Interactions
– Aminoglycosides, oral anticoagulants, ETOH
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Cephalosporins
Nursing Considerations for Patients Receiving Cephalosporins
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: CefaclorPrototype Summary: Cefaclor
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
You are writing a plan of care for a patient receiving Cefaclor. What would be an appropriate nursing diagnosis for this patient?
A. Deficient fluid volume and imbalanced nutrition: Less than body requirements, related to diarrhea
B. Chronic pain related to GI, CNS effects of drug
C. Monitor renal function test values
D. Perform culture and sensitivity tests at the site of infection
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
a. Deficient fluid volume and imbalanced nutrition: Less than body requirements, related to diarrhea
Rationale: Nursing diagnoses related to drug therapy might include: Acute Pain related to GI, CNS effects of drug; Risk for infection related to repeated injections; Deficient fluid volume and imbalanced nutrition: Less than body requirements, related to diarrhea; Deficient knowledge regarding drug therapy
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
FluoroquinolonesFluoroquinolones• Relatively new class of antibiotics with a broad spectrum of activity
• Indications: Treating infections caused by susceptible strains of gram-negative bacteria. Includes: urinary track, respiratory track, and skin infections
• Actions: Interferes with DNA replication in susceptible gram-negative bacteria, preventing cell reproduction
• Pharmacokinetics:
– Absorbed in GI tract
– Metabolized in the liver
– Excreted in urine and feces
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Fluoroquinolones (cont.)Fluoroquinolones (cont.)
• Contraindications
– Known allergy, pregnancy, or lactating women
• Adverse Effects
– Headache, dizziness, GI upset
• Drug-to-Drug Interactions
– Antacids, quinidine, theophylline
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Fluoroquinolones
Nursing Considerations for Patients Receiving Fluoroquinolones
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: CiprofloxacinPrototype Summary: Ciprofloxacin
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
What is a contraindication to receiving a fluoroquinolones?
A. Over 65 years
B. Weight under 100 pounds
C. Fluoroquinolones are contraindicated in patients with known allergy to any fluoroquinolone.
D. History of cancer
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
c. Fluoroquinolones are contraindicated in patients with known allergy to any fluoroquinolone.
Rationale: Fluoroquinolones are contraindicated in patients with known allergy to any fluoroquinolone and in pregnant or lactating patients because potential effects on the fetus and infant are not known.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Penicillins and Penicillinase - Resistant Antibiotics
Penicillins and Penicillinase - Resistant Antibiotics
• Therapeutic Actions and Indications
• Pharmacokinetics
• Contraindications and Cautions
• Adverse Effects
• Clinically Important Drug–Drug Interactions
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Penicillins and Penicillinase-
Resistant Antibiotics
Nursing Considerations for Patients Receiving Penicillins and Penicillinase-
Resistant Antibiotics
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: AmoxicillinPrototype Summary: Amoxicillin
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
SulfonamidesSulfonamides• Drugs that inhibit folic acid synthesis
• Action
– Interfere with the cell wall–building ability of bacteria when they divide
• Indications
– Treatment of infections caused by gram-negative and gram-positive bacteria
• Pharmacokinetics
– Well absorbed from the GI tract
– Metabolized in the liver, excreted in the urine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sulfonamides (cont.)Sulfonamides (cont.)
• Contraindications
– Allergy, pregnancy
• Adverse Effects
– GI symptoms; Renal effects related to the filtration of the drug
• Drug-to-Drug Interactions
– Cross sensitivity with thiazide diuretics
– Sulfonylureas
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Sulfonamides
Nursing Considerations for Patients Receiving Sulfonamides
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: CotrimoxazolePrototype Summary: Cotrimoxazole
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
TetracyclinesTetracyclines
• Developed as semisynthetic antibiotics based on the structure of a common soil mold
• Action
– Inhibits protein synthesis in susceptible bacteria, preventing cell replication
• Indications
– Treatment of various infections caused by susceptible strains of bacteria; acne when penicillin is contraindicated for eradication of susceptible organisms
• Pharmacokinetics
– Adequately absorbed from the GI tract
– Concentrated in the liver, excreted unchanged in the urine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Tetracyclines (cont.)Tetracyclines (cont.)
• Contraindications
– Allergy, pregnancy, and lactation
• Adverse Effects
– GI, Skeletal – damage to bones and teeth
• Drug-to-Drug Interactions
– Penicillin G, oral contraceptive therapy, methoxyflurane, digoxin
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Tetracyclines
Nursing Considerations for Patients Receiving Tetracyclines
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: TetracyclinePrototype Summary: Tetracycline
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
Tell whether the following statement is true or false.
Sulfonamides should not be given with thiazide diuretics because of a cross sensitivity of the drugs.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
True
Rationale: Drug-to-Drug Interactions: Cross sensitivity with thiazide diuretics; Sulfonareas
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AntimycobacterialAntimycobacterial
• Contain pathogens causing TB and leprosy
• Action
– Act on the DNA of the bacteria leading to lack of growth and eventual bacterial death
• Indications
– Treatment of acid fast bacteria
• Pharmacokinetics
– Well absorbed from the GI tract
– Metabolized in the liver, excreted in the urine
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AntimycobacterialAntimycobacterial
• Contraindications
– Allergy, renal or hepatic failure
• Adverse Effects
– CNS effects and GI irritation
• Drug-to-Drug Interactions
– Rifampin and INH can cause liver toxicity
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Antimycobacterials
Nursing Considerations for Patients Receiving Antimycobacterials
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: IsoniazidPrototype Summary: Isoniazid
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Other AntibioticsOther Antibiotics
• Ketolides
– Therapeutic Actions and Indications
– Pharmacokinetics
– Contraindications and Cautions
– Adverse Effects
– Clinically Important Drug-Drug Interactions
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: TelithromycinPrototype Summary: Telithromycin
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Other Antibiotics (cont.)Other Antibiotics (cont.)
• Lincosamides
– Therapeutic Actions and Indications
– Pharmacokinetics
– Contraindications and Cautions
– Adverse Effects
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: ClindamycinPrototype Summary: Clindamycin
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Other Antibiotics (cont.)Other Antibiotics (cont.)
• Macrolides
– Therapeutic Actions and Indications
– Pharmacokinetics
– Contraindications and Cautions
– Adverse Effects
– Clinically Important Drug–Drug Interactions
– Clinically Important Drug–Food Interactions
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: ErythromycinPrototype Summary: Erythromycin
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Other Antibiotics (cont.)Other Antibiotics (cont.)
• Monobactam Antibiotic
– Therapeutic Actions and Indications
– Pharmacokinetics
– Contraindications and Cautions
– Adverse Effects
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Summary: AztreonamPrototype Summary: Aztreonam
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Patients Receiving Other Antibiotics
Nursing Considerations for Patients Receiving Other Antibiotics
• Assessment: History and Examination
• Nursing Diagnoses
• Implementation With Rationale
• Evaluation
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
The macrolide antibiotics have known food-drug interactions. What would you teach your patient taking a macrolide antibiotic?
A. Take with meals
B. Take daily just before going to bed
C. Take daily upon arising in the morning
D. Take 1 hour before or at least 2 to 3 hours after meals
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
D. Take 1 hour before or at least 2 to 3 hours after meals
Rationale: Food in the stomach decreases absorption of oral macrolides. Therefore, administer the antibiotic on an empty stomach with a full, 8-oz glass of water, 1 hour before or at least 2 to 3 hours after meals.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
New Classes of Antibiotics and Adjuncts New Classes of Antibiotics and Adjuncts
• Daptomycin
• Linezolid (Zyvox)
• Tigecycline
• Streptogramins
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Antibiotic Use Across the Life SpanAntibiotic Use Across the Life Span
• Pediatric Population
• Adult Population
• Geriatric Population